Home/Filings/4/0001209191-23-046585
4//SEC Filing

Pomerantz Roger 4

Accession 0001209191-23-046585

CIK 0001061027other

Filed

Aug 17, 8:00 PM ET

Accepted

Aug 18, 4:51 PM ET

Size

5.8 KB

Accession

0001209191-23-046585

Insider Transaction Report

Form 4
Period: 2023-08-16
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-08-16+15,00015,000 total
    Exercise: $1.23Exp: 2033-08-16Common Stock (15,000 underlying)
Footnotes (1)
  • [F1]1/12th of the shares subject to the option shall vest each month following the Vesting Commencement Date (as defined below), or if earlier 100% of the shares subject to the option shall vest on the date of the Issuer's next annual stockholder meeting, in each case subject to the reporting person remaining a Service Provider (as defined in the 2021 Equity Incentive Plan) through the applicable vesting date. The Vesting Commencement Date is June 9, 2023.

Issuer

Viracta Therapeutics, Inc.

CIK 0001061027

Entity typeother

Related Parties

1
  • filerCIK 0001614936

Filing Metadata

Form type
4
Filed
Aug 17, 8:00 PM ET
Accepted
Aug 18, 4:51 PM ET
Size
5.8 KB